Pathstone Holdings’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-2,137
Closed -$277K – 2366
2025
Q2
$277K Sell
2,137
-257
-11% -$37.3K ﹤0.01% 1951
2025
Q1
$381K Sell
2,394
-167
-7% -$30.2K ﹤0.01% 1844
2024
Q4
$475K Sell
2,561
-250
-9% -$48.5K ﹤0.01% 1737
2024
Q3
$593K Buy
2,811
+952
+51% +$165K ﹤0.01% 1646
2024
Q2
$249K Sell
1,859
-1,479
-44% -$280K ﹤0.01% 2037
2024
Q1
$717K Buy
3,338
+746
+29% +$146K ﹤0.01% 1499
2023
Q4
$527K Buy
+2,592
New +$420K ﹤0.01% 1475

Other funds holding INSP

Pathstone Holdings's INSP Position: Q3 2025 in Review

Pathstone Holdings sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 2,137 shares — an estimated $277K sold.

Pathstone Holdings first reported a position in INSP in Q4 2023 and held it in 7 quarters. The position peaked at $717K in Q1 2024. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Pathstone Holdings reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Pathstone Holdings sold 2,137 Inspire Medical Systems shares in Q3 2025, an estimated $277K.
  • Pathstone Holdings first reported a position in Inspire Medical Systems in Q4 2023 and held it in 7 quarters.
  • Pathstone Holdings's Inspire Medical Systems position peaked at $717K in Q1 2024.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Pathstone Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.